Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

por Taheri, Hoda, Malek, Mojtaba, Ismail-Beigi, Faramarz, Zamani, Farhad, Sohrabi, Masoudreza, Reza babaei, Mohammad, Khamseh, Mohammad E.
Publicado 2020